<DOC>
	<DOC>NCT01487941</DOC>
	<brief_summary>The purpose of this study is the evaluation of safety and efficacy of the pacemaker lead "Setrox JS".</brief_summary>
	<brief_title>Setrox JS Master Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Meet the indications for pacemaker therapy Available for followup visits on a regular basis at the investigational site Contractual capability and ability to consent Age â‰¥18 years Meet one or more of the contraindications for pacemaker therapy Permanent atrial fibrillation Have a life expectancy of less than six months Cardiac surgery in the next six months Enrolled in another cardiac clinical investigation Have other medical devices that may interact with the implanted pacemaker Pregnant and breastfeeding women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>